|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-8-15
|
|
pubmed:abstractText |
Rituximab has been increasingly used in autoimmune blistering dermatoses, mainly in pemphigus. However, only a few larger case series are available on this subject and information on the efficacy of retreatment with rituximab during relapses is lacking.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1097-6787
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
552-8
|
|
pubmed:meshHeading |
pubmed-meshheading:21641080-Adult,
pubmed-meshheading:21641080-Aged,
pubmed-meshheading:21641080-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:21641080-Chemotherapy, Adjuvant,
pubmed-meshheading:21641080-Female,
pubmed-meshheading:21641080-Humans,
pubmed-meshheading:21641080-Immunologic Factors,
pubmed-meshheading:21641080-Immunosuppressive Agents,
pubmed-meshheading:21641080-Male,
pubmed-meshheading:21641080-Middle Aged,
pubmed-meshheading:21641080-Pemphigoid, Bullous,
pubmed-meshheading:21641080-Pemphigus
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients.
|
|
pubmed:affiliation |
Department of Dermatology, University of Lübeck, Lübeck, Germany. Michael.Kasperkiewicz@uk-sh.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
